Amadix (private company)

See something wrong or missing? Let us know
Offices:
Valladolid, Madrid
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Amadix is a biotechnology company constituted by the partners of TCD Pharma for the development of diagnostic tools in the area of ​​oncology, with several very advanced programs in lung and colon cancer. Its solution, called Colofast, allows to detect if a healthy person will suffer from colon cancer up to fifteen years before showing the first symptoms.

Companies with similar profile to Amadix:

CompanyCriteria
Spain Ability Pharma
56%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Parlem Telecom
54%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • At least one other investor: TheCrowdAngel
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain ViveBiotech
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Gesynta Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden Asarina Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark Cirqle Biomedical
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Gradientech
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden Trialbee
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Finland Forendo Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Iceland 3Z Pharmaceuticals
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden iCellate
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Norway CardioMech
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Norway Prediktor
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Finland Desentum
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Finland Aiforia
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes